Nalabest

Antihypertensive Besilato of equivalent amlodipino to... 5 amlodipino mg THERAPEUTIC INDICATIONS: Hypertension: AMLODIPINO is suitable as initial treatment of first election of the arterial hypertension and it can be used as monoterapia for the control of the arterial sanguine pressure in most of the patients. Those sick persons that are not appropriately controlled with an alone one antihypertensive they can benefit when adding AMLODIPINO, which has been used in combination with diuretic tiazídicos, blocking agents of adrenorreceptores beta, blocking alpha, or inhibitors of the enzyme angiotensina convertidora. AMLODIPINO is also indicated to reduce the risk of coronary fatal illness and of heart attack to the non fatal miocardio, and to reduce the risk of vascular cerebral illness. Arterial coronary illness: AMLODIPINO is suitable to reduce the risk of coronary revascularización and the necessity of hospitalization due to angina in patient with arterial coronary illness. Angina stable chronicle: AMLODIPINO is suitable for the treatment of first election in the isquemia of the miocardio, for fixed (stable angina) obstruction and/or vasospasmo / vasoconstricción (varying angina of Prinzmetal) of the coronary glasses. AMLODIPINO can be used in those cases in that the square clinical initial suggests a possible vasospasmo / vasoconstricción component, although these you has not confirmed. AMLODIPINO can be used as monoterapia, or in combination with another medication antianginoso in patient with refractory angina to the nitrates and/or appropriate dose of betabloqueadores. Ref:  Kendric  lab. Hypertension. Ischemia. Angina. Angioplsasty. Coronary artery disease

Alderan or Losartan is an angiotensin II receptor antagonist drug used mainly to treat high blood pressure (hypertension). Losartan was the first angiotensin II antagonist to be marketed. Losartan potassium is marketed by Merck & Co. Inc. under the trade name Cozaar. Losartan is available in generic form.  As with all angiotensin II type 1 receptor (AT1) antagonists, losartan is indicated for the treatment of hypertension. It may also delay progression of diabetic nephropathy and is associated with a positive clinical outcome in that regard. It therefore is a suitable pharmacological agent for the reduction of renal disease progression in patients with type 2 diabetes, hypertension and microalbuminuria  or proteinuria  .  RTef:  Blood presure.  Maver Lab.